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Abstract. The COON terminus of decay-accelerating
factor (DAF) contains a signal that directs glycophos-
phatidylinositol (GPI) membrane anchor attachment in
a process involving concerted proteolytic removal of
28 COOH-terminal residues . At least two elements are
required for anchor addition : a COOH-terminal hydro-
phobic domain and a cleavage/attachment site located
NH 2-terminal to it, requiring a small amino acid as the
acceptor for GPI addition . We previously showed that
the last 29-37 residues of DAF, making up the 000H-
terminal hydrophobic domain plus 20 residues of the
adjacent serine/threonine-rich domain (including the
anchor addition site), when fused to the COOH termi-
nus of human growth hormone (hGH) will target the
fusion protein to the plasma membrane via a GPI an-
chor. In contrast, a similar fusion protein (hGH-LDLR-
DAF17, abbreviated HLD) containing a fragment of
the serine,threonine-rich domain of the LDL receptor
(LDLR) in place of the DAF-derived serine/threonine-
rich sequences, does not become GPI anchored . We
now show that this null sequence for GPI attachment
can be converted to a strong GPI signal by mutating
a pair of residues (valine-glutamate) in the LDLR se-
W
HILE most integral membrane proteins are an-
chored to the lipid bilayer by hydrophobic trans-
membrane sequences, a small but diverse class of
cell surface proteins is held on the plasma membrane by
covalent attachment of a glycophosphatidylinositol (GPI)'
structure (for reviews seeCross, 1990 ; Low, 1989 ; Ferguson
and Williams, 1988) . The GPI membrane anchor, contain-
ing phosphatidylinositol, carbohydrate andethanolamine, is
apparently preassembled in the ER (Masterson et al ., 1989)
andthen added to theCOOH terminus ofthe protein in apro-
cessing event involving coordinated proteolytic removal of
17-31 residues from the nascent chain (Boothroyd et al .,
1981 ; Tse et al ., 1985) . This processing event is thought to
take place in the ER (Bangs et al ., 1985, 1986 ; Ferguson et
al ., 1986) and is directed by asignal at theCOOH terminus
1 . Abbreviations used in this paper : DAF, decay-accelerating factor ; GPI,
glycophosphatidylinositol ; LDLR, low-density lipoprotein receptor; PIPLC,
phosphatidylinositol-specific phospholipase C .
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quence at a position corresponding to the normal cleav-
age/attachment site, to serine-glycine, as found in the
DAF sequence . A single mutation (converting valine at
the anchor addition site to serine, the normal acceptor
for GPI addition in DAF) was insufficient to produce
GPI anchoring, as was mutation of the valine-gluta-
mate pair to serine-phenylalanine (a bulky residue) .
These results suggest that a pair of small residues (pre-
sumably flanking the cleavage point) is required for
GPI attachment . By introducing the sequence serine-
glycine (comprising a cleavage-attachment site for GPI
addition) at different positions in theLDLR sequence
of the fusion protein, HLD, we show that optimal GPI
attachment requires a processing site positioned 10-12
residues NH2-terminal to the hydrophobic domain, the
efficiency anchor attachment dropping off sharply as
the cleavage site is moved beyond these limits . These
data suggest that the GPI signal consists solely of a hy-
drophobic domain combined with aprocessing site com-
posed of a pair of small residues, positioned 10-12
residues NH2-terminal to the hydrophobic domain . No
other structural motifs appear necessary.
of the protein (Cacas et al ., 1987a) . Although all GPI-an-
chored proteins arepresumablyprocessedbyacommonpath-
way, there is no primary sequence homology or obvious con-
sensus among different GPI-anchored proteins, suggesting
that the signal forGPI attachment is of ageneral nature . The
only feature common to all GPI-anchored proteins is the
presence of a short (15-20 residues) COOH-terminal hydro-
phobic domain (predicted by the cDNA but absent from the
final GPI-anchored product) . Deletion of this domain con-
verts the GPI-anchored protein toasecreted protein suggest-
ing that the C0011-terminal hydrophobic domain plays an
important role in GPI attachment (Cacas et al ., 1989) .
We have used the GPI-anchored protein, decay-accelerat-
ing factor (DAF) (Davitz et al ., 1986; Medof et al ., 1986),
as a model system to analyze the signal for anchor attach-
ment . The last 37 amino acids predicted by the DAFcDNA
contain the information required forGPIaddition, andwhen
fused to theCOOH terminus of a normally secreted protein
will target the fusion protein to the plasma membrane by
329means of a GPI anchor (Caras et al ., 1987a) . This DAF se-
quence contains at least two elements necessary for anchor
attachment : a 17-residue COOH-terminal hydrophobic do-
main that is necessary but insufficient, and a cleavage/attach-
ment site for the anchor located N112-terminal to the hydro-
phobic domain (Caras et al., 1989) .
During normal processing, a 28-residue peptide (includ-
ing the 17-residue hydrophobic domain) is removed from the
DAF COON terminus and the GPI anchor is then added to
Ser319, which forms thenewCOOH terminus (Moran et al .,
1991) . Systematic replacement of Ser319 with all possible
amino acids suggested that the anchor addition site of DAF
(in the context of a human growth hormone [hGHJ-DAF fu-
sion protein) requires a residue with a small side chain (Sec,
Gly, Ala, Asp, or Asn) . A similar conclusion was reached
in a study using alkaline phosphatase (Micanovic et al . ,
1990) although in the latter case, cysteine was also able to
function as an acceptor for the GPI anchor. The six amino
acids listed above, and only these, have been found at the
known COOH termini of natural GPI-anchored proteins
(Cross, 1990) . ReplacementofSer319withalternative amino
acids having larger side chains severely impairs or abolishes
anchor addition, suggesting that the requirement for a small
amino acid at the attachment site is a major constraint ofthe
GPI signal (Moran et al ., 1991) .
Using a GPI-anchored fusion protein containing the last
37 amino acids ofDAF fused to theCOOH terminus of hu-
man growth hormone (hGH-DAF37), we showed that the
COOH-terminal 29 residues ofDAF (comprising the attach-
ment site serine and the 28-residue peptide that is removed
during processing) are sufficient to direct anchor attach-
ment, suggesting that sequences immediately NH2-terminal
to the attachment site are not required for GPI-anchoring
(Moran et al ., 1991) . We now address the following ques-
tion : apart from a limited specificity at the anchor addition
site and the requirement for a C0011-terminal hydrophobic
domain, are there additional structural or conformational
features necessary for GPI anchor addition? In particular,
how important are the sequences located between the anchor
attachment site and the C0011-terminal hydrophobic do-
main? Such problems are usually approached using substitu-
tion or deletion mutagenesis to pinpoint critical residues or
sequences . However, the general nature of the GPI signal
suggested thatthe results ofsuch a study might be ambiguous
and difficult to interpret . We therefore approached the prob-
lem from the opposite direction by starting with a sequence
that does not signal anchor addition and asking what changes
are required to convert it to a GPI signal . We show that a
null (nonfunctional) sequence for GPI attachment, consist-
ing of a fragment of the serine/threonine-rich domain of the
LDL receptor (LDLR) combined with the DAF 000H-
terminal hydrophobic domain, can be converted to a strong
GPI signal by the insertion ofa pair of small residues (form-
ing a cleavage/attachment site) positioned at an appropriate
distance (10-12 residues) N112-terminal to the hydrophobic
domain .
Materials andMethods
Phosphatidylinositol-specific phospholipase C (PIPLC) purified from Ba-
cillus thuringiensiswasprovided by Dr. MartinG. Low (Columbia Univer-
sity, New York) . Purified rabbit or goat antibodies against hGH were
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providedby the Medicinal Analytical Chemistry Department atGenentech,
Inc. (South San Francisco, CA) ; IgG coupled to fluorescein was from Cap-
pel Laboratories (Malvern, PA) ; [3H]ethanolamine was from Amersham
Corp. (Arlington Heights, IL) . Oligonucleotides were provided by Mark
Nasser, Parkash Jhurani, and Peter Ng (Genentech, Inc .) .
RecombinantPlasmidsandFusion Proteins
hGH-DAF37 andhGH-LDLRDAF (HLD) were constructed as previously
described (Caras et al ., 1989) . hGH-LDLR-S 12DAF17 (HLD.S 12), hGH-
LDLR-S 12G.DAF17 (HLD.S12G) and hGH-LDLRS12FDAF17 (HDL.S 12F)
were constructed fromHLD by oligonucleotide-directedmutagenesis using
aphagemid vector (McClary et al ., 1989) .HLD.S9G,HLD.S6G,HLD.S 4G,
HLD.S'G, and HLD.S 16G were similarly constructed fromHLD by oligo-
nucleotide-directed mutagenesis . After mutagenesis, an 840-bp Bgln-NotI
fragment containing the COOH terminus of hGH together with theLDLR
and DAF sequences of eachHLD derivative was subcloned into a mamma-
lian expression vector containing the NH2-terminal portion ofhGH and a
cytomegalovirus enhancer/promoter . All recombinant plasmids were veri-
fied by sequencing .
Transfections, Metabolic Labeling,
andImmunoprecipitation
COS cells were transfected using the DEAF dextran method as described
by Selden (1987) using 2 pg ofplasmidDNA per 35-mm dish and DEAE-
dextran at 400 14g/ml . Metabolic labeling ofcells with [31S]methionine and
analysis of proteins by immunoprecipitation was as previously described
(Caras et al ., 1989) .
Immunofluorescent Labeling ofCells
Immunofluorescentlabeling ofintact cells (cellsurface labeling)or permea-
bilized cells (internal labeling) was carried out essentially as described
(Caras et al ., 1987b) except that 0.5% Triton X-100/PBS was used to per-
meabilize the cells. Cells were incubated with a purified rabbit antibody
against hGH, followed by fluorescein-conjugated goat anti-rabbitantiserum
(Cappel Laboratories) .
hGH-ELISA
hGH levels were measured by an ELISA, using 96-well dishes coated with
goat anti-hGH IgG (2 pg/ml in 0.05M bicarbonate buffer, pH 9.6) . Follow-
ing incubation with antigen, the plates were treated with peroxidase-
conjugated goat anti-hGH IgG in PBS, 0.1% bovine serum albumin . Color
was developed using as a peroxidase substrate, o-phenylenediamine tablets,
5 mg (Sigma 86912 ; SigmaChemical Co., St . Louis, MO) in 12 .5 ml PBS,
0.012% H202 . The reaction was stopped by adding an equal volume of
4.5 N H2SO4 and the optical density at 490 and 405 run was determined .
The assay detected hGH in the range 2-100 ng/ml .
Results
Conversion ofa Nonfunctional Sequence
forGPIAttachment to aGPISignal
Previous work has shown that the last 29-37 residues
predicted by the DAF cDNA, when fused to the COOH ter-
minus ofhGH (as inhGH-DAF37 [Fig. 1]) will target the fu-
sion protein to the plasma membrane via a GPI anchor (Mo-
ran et al., 1991 ; Caras et al., 1989) . This DAF sequence is
comprised ofa 17-residue COOH-terminal hydrophobic do-
main plus 12-20 residues of the adjacent serine/threonine-
rich domain that both contains the anchor addition site and
serves as a substrate for 0-linked glycosylation necessary to
stabilizeDAF on the plasma membrane (Reddy et al ., 1989) .
In contrast, a sequence containing theDAF hydrophobic do-
main combined with a 15-residue fragment of a functionally
similar serine-threonine-rich domain found in the LDLR
(Cummings et al ., 1983 ; Russell et al., 1984) fails to direct
anchor attachment when fused to the COOH terminus of
330Figure 1. Schematic diagram showing the COOH-terminal se-
quences ofhGH-DAF37 andhGH-LDLR-DAF (HLD) fusion pro-
teins . (Smallprint) hGH COOH-terminus ; (boxed sequence) DAF
hydrophobic domain . The LDLR sequence ofHLD is indicated .
An arrow denotes the normal cleavage point in the DAF sequence
ofhGH-DAF37 and the anchor addition site, Ser319, is underlined .
Residues in HLD.S 12 , HLD.S 12G, and HLD.S'ZF that were altered
by in vitro mutagenesis are indicated by an underline.
hGH (as in the fusion protein HLD [Fig . 1]) (Caras et al.,
1989) . As a means to further elucidate the structural features
of the GPI signal we asked the following questions : (a) why
does the DAF-derived sequence of hGH-DAF37 direct an-
chor attachment while the LDLR-DAF sequence of HLD
does not? (b) What changes are required to convert the
LDLR-DAF sequence ofHLD into a GPI signal?
A comparison of the hGH-DAF37 and HLD 000H-
terminal sequences revealed one potentially critical differ-
ence at the position of the anchor addition site located at
Ser319 in the DAF sequence, 12 residues NHz-terminal to
the hydrophobic domain (Fig . 1) . HLD contains a valine at
this position and since valine is not one ofthe six small amino
acidsknown to be allowed at the anchor addition site (Moran
et al ., 1991 ; Micanovic et al ., 1990), we mutated this va-
line to serine, producing a new fusion protein, HLD.S'2
(Fig . 1) . Secondly, inspection of the known cleavage sites of
naturally occurring GPI-anchored proteins suggests that a
small amino acid is usually found on the COON-terminal
side of the cleavage point . For example, in the DAF se-
quence, this position is occupied by glycine (Gly320 ; Fig . 1),
whereas HLD contains glutamate. We therefore constructed
HLD.S'ZG (Fig . 1), converting the valine-glutamate at posi-
tions 12 and 11 (relative to the hydrophobic domain) ofHLD
to serine-glycine . Finally, to test the hypothesis that large or
bulky amino acids may not be tolerated at the position im-
mediately COOH-terminal to the cleavage point, we con-
structed HLD.S'ZF (Fig . 1), containing phenylalanine at
this position with serine at the addition site (12 residues
NH z-terminal to the hydrophobic domain) .
These fusion proteins were transiently expressed in COS
cells under control of the cytomegalovirus promoter. Cells
were labeled with [35S]methionine and hGH was immuno-
precipitated from both cell extracts and culture media using
a purified goat anti-hGH antibody. All of the fusion were
localized primarily in the cell lysates (Fig. 2), with only
trace amounts being found in the media (not shown) . As has
been previously reported two forms ofhGH-DAF37 can be
detected in cell lysates, a lower molecular weight, GPI-
linked form and a larger species representing uncleaved, un-
processed fusion protein (Moran et al., 1991) . Of the vari-
ous HLD constructs tested only HLaS'ZG showed a similar
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Figure 2 . Immunoprecipitation
of fusion proteins from 1s5S]-
methionine-labeled,transfected
COS cells . COS cells were
labeled with [s5S]methionine
24 h after transfection with
DNAs encoding fusion pro-
teins as indicated . The pro-
teins were immunoprecipitated
from cell lysates using a pu-
rified goat antibody against
hGH .
doublet pattern suggesting that processing had occurred
(Fig . 2, lane S) .
To test for cell surface expression of these HLD fusions,
we analyzed the cells by indirect immunofluorescence.
Staining ofintact cells revealed that ofthe HLD fusions only
HLD.S 12G was expressed on the cell surface, as is hGH-
DAF37 (Fig . 3, left) . Immunofluorescence analysis of per-
meabilized cells confirmed that all ofthe fusion proteins are
efficiently expressed and suggested that HLD, HLD.S'2 and
HLD.S'ZF are localized in the ER as well as in a Golgi
compartment-like organelle located on one side of the nu-
cleus. In contrast, HLD.S'ZG is present on the plasmamem-
brane as well as in these internal organelles (Fig . 3, right) .
Tb test whether the HLD.S 12G protein expressed on the
cell surface is GPI-anchored, the cells were incubated with
PIPLC from Bacillus thuringiensis, and the released hGH
was measured by anELISA . We observed PIPLC-dependent
release of the GPI-anchored protein hGH-DAF37 and of
HLD.S' 2G (Table I), indicating that the latter is anchored
by aGPI anchor. No release was observed with cells express-
ing HLD, HLD.S'z or HLD.S'2F confirming that these pro-
teins are not GPI anchored on the cell surface . The above
results suggest that two point mutations, resulting in the sub-
stitution ofvaline-glutamate with serine-glycine, at positions
12 and 11 NH z-terminal to the hydrophobic domain, are
sufficient to convert the non-GPI-anchored protein, HLD, to
a GPI-linked cell surface protein . These mutations presum-
ably create a recognizable cleavage/attachment site for the
GPI anchor.
Pbsition ofthe Cleavage/Attachment Site Relative to
the Hydrophobic Domain
We next asked how important is the position of the serine-
glycine cleavage/attachment site relative to the hydrophobic
domain? To address this we introduced a series of serine-
glycine substitutions in the HLD sequence, placing the ser-
ine at positions 9, 6, 4, 2, and 16 NHZ-terminal to the hydro-
phobic domain inHLD.S9G, HLD.S6G, HLD.S4G, HLD.SIG
and HLD.S'6G, respectively (Fig . 4) . These fusion proteins
were transiently expressed in COS cells, and after labeling
of the cells with [ 35S]methionine we analyzed both cell ly-
sates andculture mediaby immunoprecipitation . As observed
above, all of the fusion proteins were localized primarily in
the cell lysates (Fig . 5), essentially no protein being detected
in the media (not shown) . Ofthe mutant proteins tested only
HLD.S'zG (containing serine-glycine at positions 12 and 11)
showed evidence ofprocessing, suggested by the doublet pat-
tern upon electrophoresis (Fig . 5, lane 2) .
To test whether the cell-associated fusion proteins were on
331Figure 3 . Immunofluorescent labeling of transfected COS cells expressing fusion proteins as indicated. (Left) Fixed, nonpermeabilized
cells labeled as described in Materials and Methods, showing cell surface protein . (Right) Permeabilized cells .
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332Table L ELISA ofhGHin Supernatantsfrom Transfected
COS Cells Incubated with or withoutPIPLC
Transfected cells growth in 60-mm dishes were removed with 7mm EDTA in
PBS, washed, and resuspended in 10% FCS/PBS . Aliquots containing 106
cells in 100 Al were incubated in the presence or absence of PIPLC (3.9 U/ml)
for 60 min at 37°C . The cells were then removedby centrifugation and hGH
released into the supernatants was measured by an ELISA as described in
Materials andMethods . Shown is a representative of three experiments .
the cell surface we analyzed the cells by indirect immunoflu-
orescence . Staining of intact cells (Fig. 6, left) suggested that
whereas HLD.S'2G was strongly expressed on the cell sur-
face ofmany cells in the preparation, HLD.S 9G was present
at moderate levels on fewer cells, and HLD.S6G, HLD.S°G,
HLD.S2G, and HLD.S'6G were essentially undetectable on
the cell surface . As previously observed, analysis of perme-
abilized cells (Fig . 6, right) suggested that the latter proteins
are localized in the ER and possibly the Golgi apparatus . In
addition we also observed staining of vesicular structures
scattered throughout the cytoplasm (Fig . 6, see HLD.S°G
staining pattern) .
We next tested for the presence of GPI-anchored cell sur-
face fusion proteins by incubating transfected cells with
PIPLC and measuring the released hGH . We detected
PIPLC-dependent release of HLD.S9G (Table II) indicating
that this protein is GPI-anchored on the cell surface. How-
ever, consistent with the immunofluorescence analysis, the
level of released protein was approximately fourfold lower
than that observed with HLD.S' 2G, suggesting thatHLD.S 9G
is less efficiently processed relative to HLD.St 2G . No PIPLC-
dependent release of the remaining mutant proteins was ob-
served .
Figure 4 . Schematicdiagram showing the COOH-termini ofHLD
fusion proteins with cleavage/attachment sites (underlined) intro-
duced at various positions NH2-terminal to the hydrophobic do-
main . (Boxed sequence) DAF hydrophobic domain ; (large print)
unboxed, LDLR sequence ; (small print) hGH COOH-terminal
sequence.
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Figure 5 . ImmunoprecipitationofHLD fusion proteins containing
cleavage/attachment sites at various positions relative to thehydro-
phobic domain . HLD fusion proteins as indicated were immuno-
precipitated from cell lysates derived from transfected COS cells
after labeling with ["Slmethionine .
To confirm that HLD.S' 2G and HLD.S9G are GPI-an-
chored and to rule out the possibility that the intracellular
mutant proteins contain anchors, we labeled the cells with
[ 3H]ethanolamine and analyzed them by immunoprecipita-
tion . Of the seven fusion proteins tested only HLD.S' 2G
was strongly labeled with [3H]ethanolamine (Fig . 7, lane 2) .
Weak labeling ofHLD.SIG (lane 4) confirmed that this pro-
tein does become GPI-linked, although considerably less
efficiently than HLD.S'2G . No labeled bands were observed
with cells expressingHLD, HLD.St6G, HLD.S6G, HLD.S4G,
or HLD.S2G, confirming that these fusion proteins do not
become GPI anchored . These results suggest that the effi-
ciency of GPI anchor attachment decreases sharply as the
processing site is moved closer to, or further from, the hy-
drophobic domain, the optimal distance being between 10
and 12 residues N112-terminal to the hydrophobic domain .
Discussion
GPIAttachment Requires a Pair ofSmall Residues
Flanking the Cleavage Site
Previous reports have localized the signal for GPI anchor at-
tachment to the COOH-terminal 29 residues of DAF and
shown that this signal contains at least two critical elements :
a 17-residue, COOH-terminal hydrophobic domain and a
cleavage/attachment site for the anchor, located within the
adjacent sequence (at Ser319, 12 residues N112-terminal to
the hydrophobic domain) (Caras et al ., 1987a, 1989 ; Moran
et al ., 1991) . While previous work indicated that the residue
at the anchor attachment site must be small (only Ser, Gly,
Ala, Asp, Asn, and possibly Cys can function as acceptors
for the anchor [Moran et al ., 1991]), additional structural
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Fusion protein -PIPLC
hGH
+PIPLC
nglml
hGH-DAF37 5 .2 38.0
HLD <1 .0 <1 .0
HLD .S' 2 < 1 .0 < 1 .0
HLD.S'2G <1 .0 15.2
HLD.S' 2F <1 .0 < 1 .0features of the cleavage site or GPI signal remained un-
known . In this report we addressed this issue using a non-
GPI-anchored fusion protein, HLD, containing a fragment
of the serine/threonine-rich domain of the LDLR in place of
the DAF sequence immediately adjacent to the hydrophobic
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Figure 6. Immunofluorescent la-
beling of transfected COS cells
expressing HLD fusion proteins .
(Left) Intact (nonpermeabilized)
cells showing cell-surface pro-
tein ; (right) permeabilized cells .
domain . (The LDLR sequence was chosen since the DAF
sequence to be replaced forms part of a functionally simi-
lar serine/threonine-rich domain thought to be the site of
0-linked glycosylation, as in the LDLR [Reddy et al .,
1989] .) We show that a pair of substitution mutations (con-
334Table II . ELISAofhGHin Supernatantsfrom
Transfected COS CellsIncubatedwith or withoutPIPLC,
CarriedOutas Described in theLegend to TableI
verting a valine-glutamate sequence to serine-glycine) at the
position corresponding to the normal processing site in the
DAF sequence are sufficient to convert the non-GPI-linked
fusion protein, HLD, to a GPI-linked protein on the cell sur-
face. This serine-glycine pair presumably flanks the cleavage
point, with serine acting as the acceptor for anchor addition .
Both mutations were necessary to achieve anchor attach-
ment . A single substitution (valine-glutamate to serine-glu-
tamate) failed to produce a viable GPI signal . In addition,
substitution ofvaline-glutamate attheposition oftheprocess-
ing site with serine-phenylalanine did not allow GPI attach-
ment . These data suggest that in addition to a limited speci-
ficity (for small residues) at the anchor addition site, there
is a similar limited specificity at the position immediately
COOH-terminal to the cleavage point . Inspection of the
known cleavage sites of natural GPI-anchored proteins re-
veals that serine, glycine, alanine, asparagine, aspartate, and
Figure 7 . [3H]Ethanolamine labeling and inununoprecipitation of
HLD fusion proteins expressed inCOS cells . Transfected COS cells
were labeled with [3H]ethanolamine (166 p,Ci/35-mmdish) for 16 h
before immunoprecipitation from cell lysates using a purified goat
anti-hGH antibody. Equivalent amounts of protein were loaded in
all lanes .
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arginine occur at this position (Cross, 1990) . Except for ar-
ginine, this specificity is similar to that observed at the an-
chor addition site, suggesting thatboth positions require resi-
dues with small side chains . This view is supported by our
observation that a bulky residue (such as phenylalanine) at
this position abolishes anchor attachment.
Pbsition oftheCleavage/Attachment Site
Analysis ofnatural GPI anchored proteins suggests that pro-
cessing usually occurs 10 to 12 residues N112-terminal to
the hydrophobic domain (Ferguson and Williams, 1988 ;
Cross, 1990) . Using the fusion protein, HLD, containing a
null sequence for GPI attachment (lacking any potential
cleavage/attachment sites) we investigated the consequences
of introducing a cleavage site (comprising the sequence
serine-glycine) at various positions relative to the hydropho-
bic domain . Our results show that positioning of this se-
quence with the attachment site (the serine residue) placed
nine residues N112-terminal to the hydrophobic domain al-
lows GPI-addition albeit with severely reduced efficiency
compared to a similar protein containing the attachment site
at position 12 . Proteins containing attachment sites posi-
tioned 6, 4, 2, or 16 residues NH Z-terminal to the hydro-
phobic domain failed to become GPI anchored . These data
suggest that the position ofthe processing site relative to the
hydrophobic domain is a critical feature of the GPI signal .
Although the spacial topology of these two elements allows
some flexibility, our data suggest that the optimal distance
for anchor attachment is probably 10-12 residues as ob-
served in nature . As the processing site is moved further to-
wards or away from the hydrophobic domain, the efficiency
of anchor attachment drops off sharply, the GPI signal even-
tually becoming essentially nonfunctional .
Significance ofSequencesbetween theProcessing Site
and the Hydrophobic Domain
Since the LDLR sequence in HLD and the DAF sequence
that it replaced show no homology and are presumably also
conformationally different, and since the insertion of a cleav-
age site into HLD is sufficient to induce GPI anchoring, it
is not unreasonable to conclude that apart from the two
(small) residues that constitute the processing site, this
stretch of sequence does not contribute significantly to the
GPI signal other than providing a hydrophilic spacer between
the hydrophobic domain and the cleavage site . While these
conclusions remain to be tested using other hydrophilic
spacers, the complete absence of homology or recognizable
consensus patterns within this region when different GPI an-
chored proteins are compared, is consistent with this view.
We conclude that the GPI signal requires only a hydropho-
bic domain and a cleavage/attachment site consisting of a
pair of small residues, positioned 10 to 12 residues NH2-
terminal to the hydrophobic domain . These features appear
to define the constraints ofthe GPI signal, no other structural
motifs being necessary.
Received forpublication 18 March 1991 and in revised form 17 May 1991 .
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